SCI Logo
 

The Society of Chemical Industry

Username:
Password:

 
 
Click here to go to the Chemistry & Industry web site
 
Click here to go to The SupplyLine web site
 
Click here to go to the Journal of the Science of Food and Agriculture web site
 
Click here to go to the Polymer International web site
 
Click here to go to the Pest Management Science web site
 
Click here to go to the Journal of Chemical Technology and Biotechnology web site
 
Click here to go to the Biofuels, Bioproducts and Biorefining (Biofpr) web site
 
 

Search SCI

Advance Search


Related Links

Chemistry & Industry

C&I in the news

Comment on this article



Biology for Chemists

23- 24 June 2008

Biology for Chemists



Chemistry & IndustryResearchers fish for solution to allergies


Seafood allergy sufferers may soon be able to eat prawns without the fear of an adverse reaction. Lisa Richards investigates

prawnResearchers at the Ocean University of China have taken a promising step towards removing the proteins from prawns that cause an allergic response.

Scientists, led by Li Zhenxing, found that treating prawns with a combination of heat and irradiation caused a significant decrease in allergenicity.

They took blood from patients with shrimp allergies, added samples of treated and untreated prawn, and measured how antibodies in the blood reacted to allergens. Pen a 1, one of the major allergens, decreased 20-fold after treatment (Journal of the Science of Food and Agriculture doi 10.1002/jsfa.2746).

Treating prawns with irradiation alone appeared to increase reactivity with antibodies. Zhenxing’s team suggests this is because irradiation damages the proteins, revealing hidden reactive amino acid residues.

Subsequent heating, however, destroys the exposed residues. ‘Radiation and heat seems to be a promising method for reducing the immunoreactivity [of prawn],’ said the researchers.

Samuel Lehrer of Tulane University in New Orleans, US, is already working on removing allergens from prawns using genetic techniques. But Zhenxing’s method could be preferable for people wary about eating genetically modified foods.

However, a spokesperson from one of the large food companies is sceptical. ‘It seems highly unlikely there would be a viable market for such an artificially manipulated product,’ he said.

The next step is to test the treated prawns in animal models of the human allergic response. ‘If I was sensitive I wouldn’t risk eating these [prawns] until in vivo experiments have been performed,’ said Flemming Jessen of the department of seafood research in Denmark.

More than 2.1% of the adult population suffers from shellfish allergies, according to some studies. Symptoms range from localised swelling and rashes to anaphylactic shock, which can be fatal.